Phillip H. Abbosh, Ph.D. - Publications

2006 Indiana University, Bloomington, Bloomington, IN, United States 
Cell Biology, Molecular Biology, Biochemistry

6/27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2008 Abbosh PH, Zhang S, Maclennan GT, Montironi R, Lopez-Beltran A, Rank JP, Baldridge LA, Cheng L. Germ cell origin of testicular carcinoid tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 1393-6. PMID 18316560 DOI: 10.1158/1078-0432.CCR-07-4146  0.76
2008 Abbosh PH, Wang M, Eble JN, Lopez-Beltran A, Maclennan GT, Montironi R, Zheng S, Pan CX, Zhou H, Cheng L. Hypermethylation of tumor-suppressor gene CpG islands in small-cell carcinoma of the urinary bladder. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 21: 355-62. PMID 18192966 DOI: 10.1038/modpathol.3801012  0.76
2007 Abbosh PH, Li X, Li L, Gardner TA, Kao C, Nephew KP. A conditionally replicative, Wnt/beta-catenin pathway-based adenovirus therapy for anaplastic thyroid cancer. Cancer Gene Therapy. 14: 399-408. PMID 17218945 DOI: 10.1038/sj.cgt.7701024  0.76
2006 Fan M, Yan PS, Hartman-Frey C, Chen L, Paik H, Oyer SL, Salisbury JD, Cheng AS, Li L, Abbosh PH, Huang TH, Nephew KP. Diverse gene expression and DNA methylation profiles correlate with differential adaptation of breast cancer cells to the antiestrogens tamoxifen and fulvestrant. Cancer Research. 66: 11954-66. PMID 17178894 DOI: 10.1158/0008-5472.CAN-06-1666  0.76
2006 Abbosh PH, Montgomery JS, Starkey JA, Novotny M, Zuhowski EG, Egorin MJ, Moseman AP, Golas A, Brannon KM, Balch C, Huang TH, Nephew KP. Dominant-negative histone H3 lysine 27 mutant derepresses silenced tumor suppressor genes and reverses the drug-resistant phenotype in cancer cells. Cancer Research. 66: 5582-91. PMID 16740693 DOI: 10.1158/0008-5472.CAN-05-3575  0.76
2005 Abbosh PH, Nephew KP. Multiple signaling pathways converge on beta-catenin in thyroid cancer. Thyroid : Official Journal of the American Thyroid Association. 15: 551-61. PMID 16029121 DOI: 10.1089/thy.2005.15.551  0.76
Low-probability matches
2020 Correa AF, Ruth KJ, Al-Saleem T, Pei J, Dulaimi E, Kister D, Collins M, Abbosh PH, Slifker MJ, Ross E, Uzzo RG, Testa JR. Overall tumor genomic instability: an important predictor of recurrence-free survival in patients with localized clear cell renal cell carcinoma. Cancer Biology & Therapy. 1-8. PMID 32116106 DOI: 10.1080/15384047.2020.1721251  0.01
2019 Coleman* JA, Wong NC, Sjoberg DD, Silva N, Bochner BH, Dalbagni G, Donat SM, Herr HW, Cha E, Donahue T, Pietzak E, Al-Ahmadie H, Benfante N, Meraney A, Shichman S, ... ... Abbosh P, et al. LBA-17 MULTICENTER PROSPECTIVE PHASE II CLINICAL TRIAL OF GEMCITABINE AND CISPLATIN AS NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH HIGH-GRADE UPPER TRACT UROTHELIAL CARCINOMA Journal of Urology. 201. DOI: 10.1097/01.JU.0000557509.30958.AE  0.01
2018 Li Q, Damish A, Frazier ZJ, Liu D, Reznichenko E, Kamburov A, Bell A, Zhao H, Jordan EJ, Gao SP, Ma J, Abbosh PH, Bellmunt J, Plimack ER, Lazaro JB, et al. ERCC2 Helicase Domain Mutations Confer Nucleotide Excision Repair Deficiency and Drive Cisplatin Sensitivity in Muscle-Invasive Bladder Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29980530 DOI: 10.1158/1078-0432.CCR-18-1001  0.01
2018 Geynisman DM, Abbosh PH, Plimack ER, Zibelman M. Chemoimmunotherapy in Metastatic Urothelial Carcinoma. European Urology. PMID 29331216 DOI: 10.1016/j.eururo.2017.12.029  0.01
2017 Kline CLB, Ralff MD, Lulla AR, Wagner JM, Abbosh PH, Dicker DT, Allen JE, El-Deiry WS. Role of Dopamine Receptors in the Anticancer Activity of ONC201. Neoplasia (New York, N.Y.). 20: 80-91. PMID 29216597 DOI: 10.1016/j.neo.2017.10.002  0.01
2017 Gokare P, Finnberg NK, Abbosh PH, Dai J, Murphy ME, El-Deiry WS. P53 represses pyrimidine catabolic gene dihydropyrimidine dehydrogenase (DPYD) expression in response to thymidylate synthase (TS) targeting. Scientific Reports. 7: 9711. PMID 28851987 DOI: 10.1038/s41598-017-09859-x  0.01
2015 Ito T, Pei J, Dulaimi E, Menges C, Abbosh PH, Smaldone MC, Chen DY, Greenberg RE, Kutikov A, Viterbo R, Uzzo RG, Testa JR. Genomic Copy Number Alterations in Renal Cell Carcinoma with Sarcomatoid Features. The Journal of Urology. PMID 26602888 DOI: 10.1016/j.juro.2015.10.180  0.01
2015 Abbosh PH, Plimack ER. Measuring the Efficacy and Value of Urothelial Cancer Urinary Biomarkers. Annals of Internal Medicine. 163: 954-5. PMID 26501942 DOI: 10.7326/M15-2445  0.01
2015 Abbosh PH, McConkey DJ, Plimack ER. Targeting Signaling Transduction Pathways in Bladder Cancer. Current Oncology Reports. 17: 58. PMID 26472299 DOI: 10.1007/s11912-015-0477-6  0.01
2015 Mehrazin R, Smaldone MC, Egleston B, Tomaszewski JJ, Concodora CW, Ito TK, Abbosh PH, Chen DY, Kutikov A, Uzzo RG. Is anatomic complexity associated with renal tumor growth kinetics under active surveillance? Urologic Oncology. 33: 167.e7-12. PMID 25778696 DOI: 10.1016/j.urolonc.2015.01.013  0.01
2015 Ito T, Abbosh PH, Mehrazin R, Tomaszewski JJ, Li T, Ginzburg S, Canter DJ, Greenberg RE, Viterbo R, Chen DY, Kutikov A, Smaldone MC, Uzzo RG. Surgical Apgar Score predicts an increased risk of major complications and death after renal mass excision. The Journal of Urology. 193: 1918-22. PMID 25464000 DOI: 10.1016/j.juro.2014.11.085  0.01
2015 Abbosh PH, Chen DYT. Novel Research on Fusion Genes and Next-Generation Sequencing Prostate Cancer: Science and Clinical Practice: Second Edition. 29-39. DOI: 10.1016/B978-0-12-800077-9.00004-9  0.01
2014 Mehrazin R, Piotrowski Z, Egleston B, Parker D, Tomaszweski JJ, Smaldone MC, Abbosh PH, Ito T, Bloch P, Iffrig K, Bilusic M, Chen DY, Viterbo R, Greenberg RE, Uzzo RG, et al. Is extended pharmacologic venous thromboembolism prophylaxis uniformly safe after radical cystectomy? Urology. 84: 1152-6. PMID 25443917 DOI: 10.1016/j.urology.2014.06.058  0.01
2014 Mehrazin R, Uzzo RG, Kutikov A, Ruth K, Tomaszewski JJ, Dulaimi E, Ginzburg S, Abbosh PH, Ito T, Corcoran AT, Chen DY, Smaldone MC, Al-Saleem T. Lymphopenia is an independent predictor of inferior outcome in papillary renal cell carcinoma. Urologic Oncology. PMID 25027688 DOI: 10.1016/j.urolonc.2014.06.004  0.01
2013 Song JB, Tanagho YS, Kim EH, Abbosh PH, Vemana G, Figenshau RS. Camera-port site metastasis of a renal-cell carcinoma after robot-assisted partial nephrectomy. Journal of Endourology / Endourological Society. 27: 732-9. PMID 23297710 DOI: 10.1089/end.2012.0533  0.01
2013 Kim EH, Abbosh PH, Tanagho YS, Song JB, Figenshau RS. Port-Site Metastasis After Robot-Assisted Partial Nephrectomy Videourology. 27. DOI: 10.1089/VID.2012.0032  0.01
2013 Abbosh P, Nepple K, Klim A, Strope S, Dehdashti F, Siegel B, Kibel A, Grubb R. 2203 UTILITY OF FDG-PET/CT IN IDENTIFYING BONE METASTASIS IN PATIENTS WITH BLADDER CANCER Journal of Urology. 189. DOI: 10.1016/J.JURO.2013.02.2112  0.01
2012 Abbosh PH, Thom MR, Bullock A. Laparascopic capsulotomy to treat autoinflation of inflatable penile prostheses. The Journal of Sexual Medicine. 9: 1212-5. PMID 22024210 DOI: 10.1111/j.1743-6109.2011.02525.x  0.01
2011 Abbosh PH, Bhayani SB. Thermoablation of Renal Masses: The Urologist's Perspective. Seminars in Interventional Radiology. 28: 361-6. PMID 23204634 DOI: 10.1055/s-0031-1296078  0.01
2011 Abbosh PH, Grubb RL, Cao D, Humphrey PA. Hybrid renal tumors in Birt-Hogg-Dubé syndrome. The Journal of Urology. 186: 2413-4. PMID 22019161 DOI: 10.1016/j.juro.2011.09.066  0.01
Hide low-probability matches.